Background: Studies in prevalence and incidence in the United States have been limited to clinical populations and single site studies, therefore, there is a notable lack in estimates of regional differences in dementia incidence and the drivers of such disparities.
Methods: We included 1,268,599 US Veterans Health Administration (VHA) dementia-free patients aged 65 years or older living within the U.S. with a residential zip code from year 2000-2021. Dementia incidence was estimated according to US geographical areas from residential zip codes, based on the 10 Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) regions, labeled from A to J. Incident diagnosis of dementia was ascertained using the 9th and 10th editions of the International Classification of Diseases. Poisson regression models adjusted for age were used to asses differences in dementia incidence based on geographical regions, and the sensitivity of the findings were evaluated by accounting for competing risk of death.
Results: Among the 1,268,599 study participants (mean age 73.9 [SD, 6.1] years; 25 335 women [2%]; 15.5% received a diagnosis of dementia over a mean follow-up of 12.6 years. Unadjusted incidence of dementia per 1000 person-years was the lowest for the Northeast region, B and the highest in in the Southeastern region D (Figure 1). Residence within the Southeastern region D was associated a 27% higher risk of dementia, 19% higher risk in the Southern region F, 17% the midwestern region H and Northwestern region J, 12% for Southeastern region C; the remaining regions had an increased risk <10% compared to region B (Table 1). Additional adjustment for sex and race, and accounting for the competing risk of death produced similar results.
Conclusion: Among older adults who received care at VHA medical centers, there were significant geographical differences in dementia incidence across the U.S, suggesting important roles for geographically patterned risk factors. Identifying geographical differences in dementia incidence allows for a more strategic and targeted approach to healthcare planning, public health interventions, and policy development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.091877 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714844 | PMC |
J Alzheimers Dis
January 2025
Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands.
Background: Alzheimer's disease (AD) is the most prevalent form of dementia, characterized by amyloid-β plaques and neurofibrillary tangles. With an aging population, both AD and comorbidities are increasingly common. Managing comorbidities often requires multiple medications, leading to polypharmacy, defined as the concurrent use of five or more medications.
View Article and Find Full Text PDFAlzheimers Dement (N Y)
January 2025
Alzheimer Center Amsterdam Neurology Vrije Universiteit Amsterdam, Amsterdam UMC VUmc Amsterdam The Netherlands.
Introduction: Recruitment of participants for intervention studies is challenging. We evaluated the effectiveness and efficiency of a participant recruitment campaign through an online registry for the FINGER-NL study, a multi-domain lifestyle intervention trial targeting cognitively healthy individuals aged 60-79 with dementia prevention potential. Additionally, we explored which recruitment strategy successfully reached individuals from underrepresented groups in research.
View Article and Find Full Text PDFOman Med J
July 2024
Orthopedics and Traumatology Department, RSUD Kesehatan Kerja, Bandung, Indonesia.
Objectives: Research indicates that active smokers are at risk of cognitive impairment. However, the correlation between chronic passive smoking and the risk of cognitive impairment remains underexplored. This study aimed to determine the association between smoking, passive smoking, and cognitive impairment and examined the dose-response effect.
View Article and Find Full Text PDFJ Clin Nurs
January 2025
Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Aims: To examine survivors' experiences of discharge information including risk communication after hospitalisation for a stroke and the characteristics associated with receiving information in accordance with their preferences.
Background: With advances in acute stroke care and an ageing population, the number of survivors of stroke is increasing. It is important that healthcare providers ensure patients have adequate information after a stroke-related hospitalisation.
Fluids Barriers CNS
January 2025
Sanders-Brown Center on Aging, College of Medicine, University of Kentucky, 760 Press Ave, 124 HKRB, Lexington, KY, 40536-0679, USA.
Background: Blood-brain barrier dysfunction is one characteristic of Alzheimer's disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal of this study was to assess markers for barrier dysfunction in postmortem tissue samples from research participants who were either cognitively normal individuals (CNI) or diagnosed with AD at the time of autopsy and determine to what extent these markers are associated with AD neuropathologic changes (ADNC) and cognitive impairment.
Methods: We used postmortem brain tissue and plasma samples from 19 participants: 9 CNI and 10 AD dementia patients who had come to autopsy from the University of Kentucky AD Research Center (UK-ADRC) community-based cohort; all cases with dementia had confirmed severe ADNC.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!